schmallenberg
viru
sbv
emerg
orthobunyaviru
rumin
associ
outbreak
congenit
malform
abort
stillborn
anim
sinc
discoveri
novemb
sbv
spread
rapidli
mani
european
countri
develop
molecular
serolog
tool
experiment
vivo
model
platform
studi
sbv
pathogenesi
tropism
virushost
cell
interact
use
synthet
biolog
approach
develop
revers
genet
system
rapid
rescu
genet
manipul
sbv
show
sbv
wide
tropism
cell
cultur
synthet
sbv
replic
vitro
effici
wild
type
viru
develop
experiment
mous
model
studi
sbv
infect
show
viru
replic
abundantli
neuron
caus
cerebr
malacia
vacuol
cerebr
cortex
virusinduc
acut
lesion
use
understand
progress
vacuol
porencephali
extens
tissu
destruct
often
observ
abort
lamb
calv
natur
occur
schmallenberg
case
inde
detect
high
level
sbv
antigen
neuron
gray
matter
brain
spinal
cord
natur
affect
lamb
calv
suggest
muscular
hypoplasia
observ
sbvinfect
lamb
mostli
secondari
central
nervou
system
damag
final
investig
molecular
determin
sbv
virul
interestingli
found
biolog
sbv
clone
passag
cell
cultur
display
increas
virul
mice
also
found
sbv
delet
mutant
nonstructur
nss
protein
sbvdnss
less
virul
mice
wild
type
sbv
attenu
sbv
virul
depend
inabl
sbvdnss
block
ifn
synthesi
viru
infect
cell
conclus
work
provid
use
experiment
framework
studi
biolog
pathogenesi
sbv
approxim
percent
infecti
diseas
emerg
caus
arthropodborn
virus
arboviru
probabl
result
combin
factor
includ
dramat
increas
travel
commerci
exchang
climat
ecolog
chang
increas
livestock
product
addit
chang
trade
commerci
polici
creat
optim
condit
movement
infect
vertebr
host
invertebr
vector
wide
geograph
area
sever
european
countri
current
experienc
emerg
previous
uncharacter
arboviru
domest
rumin
schmallenberg
viru
sbv
sbv
infect
caus
mild
diseas
adult
cattl
character
reduc
milk
product
pyrexia
diarrhea
howev
sbv
infect
suscept
pregnant
anim
associ
musculoskelet
central
nervou
system
malform
stillborn
newborn
lamb
calv
sbv
detect
first
time
novemb
plasma
sampl
collect
cow
display
fever
diarrhea
farm
near
town
schmallenberg
germani
first
acut
infect
associ
sbv
report
august
first
malform
stillborn
anim
caus
viru
detect
netherland
decemb
sinc
countri
report
congenit
malform
stillbirth
associ
presenc
sbv
may
area
sbv
crossreact
antibodi
detect
high
cattl
survey
although
clinic
consequ
econom
impact
infect
complet
clear
yet
phylogenet
analysi
reveal
sbv
belong
genu
orthobunyaviru
within
bunyavirida
larg
famili
compris
hundr
virus
abl
infect
broad
rang
vertebr
invertebr
host
bunyavirus
signific
pathogen
human
anim
caus
rang
diseas
includ
febril
ill
oropouch
viru
enceph
la
cross
viru
hemorrhag
fever
rift
valley
fever
viru
sbv
cluster
virus
simbu
serogroup
particular
virus
speci
sathuperi
viru
includ
sathuperi
viru
satv
dougla
viru
douv
shamonda
viru
shav
current
classifi
within
shamonda
viru
speci
virus
simbu
serogroup
associ
abort
stillbirth
malform
arthrogryposi
hydranencephali
syndrom
rumin
asia
africa
oceania
akaban
viru
akav
wide
studi
member
simbu
serogroup
literatur
rel
littl
inform
diseas
associ
satv
shav
infect
virus
simbu
serogroup
detect
europ
given
sbv
found
archiv
sampl
far
like
first
introduct
sbv
europ
occur
spring
given
current
avail
data
possibl
ascertain
sbv
introduc
europ
except
hantavirus
bunyavirus
transmit
arthropod
vector
sbv
also
thought
arboviru
given
close
related
virus
simbu
serogroup
known
transmit
insect
addit
sbv
also
detect
pool
culicoid
bite
midg
denmark
bunyavirus
envelop
virus
segment
singl
strand
rna
genom
neg
ambisens
polar
viral
genom
compris
three
rna
segment
refer
small
medium
larg
l
encod
four
structur
protein
nucleocapsid
protein
n
two
glycoprotein
gn
gc
viral
polymeras
member
orthobunyaviru
encod
two
addit
nonstructur
protein
nss
nsm
nss
encod
open
read
frame
segment
overlap
n
gene
nsm
encod
segment
polyprotein
cotransl
cleav
nsm
gn
gc
nss
protein
bunyamwera
viru
bunv
prototyp
famili
nonessenti
gene
product
viral
replic
shown
play
role
inhibit
host
cell
mrna
protein
synthesi
nss
protein
contribut
viral
pathogenesi
block
product
interferon
ifn
transcript
inhibit
consequ
inhibit
innat
respons
host
studi
molecular
biolog
rna
virus
transform
develop
revers
genet
allow
rescu
infecti
viru
clone
cdna
copi
viral
genom
revers
genet
bunv
proven
invalu
unravel
underpin
mechan
viral
replic
pathogenesi
viru
famili
studi
develop
revers
genet
platform
sbv
use
character
biolog
pathogenesi
emerg
pathogen
obtain
sbv
mutant
reveal
key
determin
viral
virul
show
viral
nonstructur
protein
nss
counteract
innat
immun
host
addit
show
sbv
replic
neuron
experiment
infect
mice
natur
occur
sbv
infect
lamb
calv
first
goal
gain
insight
vitro
growth
kinet
sbv
sever
cell
line
deriv
variou
anim
speci
human
sbv
grew
effici
cell
line
test
includ
sheep
cpttert
bovin
bfae
human
dog
mdck
hamster
bsr
cell
figur
sbv
reach
titer
pfuml
h
postinfect
induc
cytopath
effect
cpe
cell
line
except
bfae
data
shown
found
sbv
replic
effici
sheep
cpttert
induc
welldefin
plaqu
approxim
mm
diamet
h
postinfect
consequ
use
cpttert
titrat
sbv
perform
studi
sever
member
bunyavirida
success
rescu
revers
genet
success
simpl
approach
involv
transfect
plasmid
encod
fulllength
antigenom
viral
rna
control
polymeras
promot
adopt
synthet
biolog
approach
obtain
plasmid
harbor
full
fulllength
antigenom
rna
viral
segment
vitro
synthesi
use
sequenc
first
sbv
isol
avail
intern
nucleotid
sequenc
databas
collabor
januari
access
number
complet
sequenc
untransl
region
utr
sbv
l
segment
unavail
time
therefor
predict
miss
sequenc
base
high
similar
sequenc
akav
rescu
plasmid
design
contain
fulllength
antigenom
rna
flank
promot
immedi
upstream
utr
hepat
ribozym
follow
termin
sequenc
immedi
downstream
utr
previous
describ
within
vector
figur
transfect
antigenomeencod
plasmid
cell
bhkderiv
cell
line
constitut
express
rna
polymeras
five
day
post
transfect
supernat
collect
presenc
viru
assess
standard
plaqu
assay
cpttert
cell
figur
neg
control
includ
cell
transfect
two
rescu
plasmid
success
rescu
sbv
follow
method
although
case
transfect
result
viabl
rescu
sbv
vitro
growth
assay
describ
appear
sbv
infect
cell
readili
thu
reason
would
schmallenberg
viru
sbv
discov
germani
near
town
schmallenberg
novemb
sinc
found
caus
malform
stillbirth
rumin
sbv
spread
rapidli
mani
european
countri
includ
netherland
belgium
franc
unit
kingdom
littl
known
biolog
properti
viru
vaccin
avail
studi
develop
approach
call
revers
genet
allow
recoveri
synthet
sbv
laboratori
condit
ii
develop
mous
model
infect
sbv
iii
show
sbv
replic
neuron
experiment
infect
mice
similar
natur
infect
lamb
calv
iv
develop
viral
mutant
pathogen
origin
viru
due
inabl
counteract
host
cell
defens
v
identifi
mutat
associ
increas
virul
work
provid
experiment
tool
understand
newli
emerg
viru
caus
diseas
rumin
addit
possibl
manipul
sbv
genom
order
develop
highli
effect
vaccin
possibl
rescu
sbv
effici
cell
line
known
highli
transfect
provid
rna
polymeras
tran
end
transfect
cell
sbv
antigenom
plasmid
along
plasmid
express
rna
polymeras
control
cmv
immedi
earli
promot
figur
sbv
effici
rescu
follow
method
found
overal
reproduc
also
abl
rescu
bunv
transient
transfect
cell
data
shown
demonstr
method
easili
appli
virus
within
famili
ssbv
rescu
either
cell
produc
plaqu
similar
size
shape
sbv
figur
addit
found
ssbv
grew
kinet
reach
approxim
titer
sbv
sheep
cpttert
bovin
bfae
cell
figur
presenc
sbv
infect
cell
confirm
western
blot
cell
lysat
infect
cell
figur
result
indic
wild
type
sbv
ssbv
display
similar
phenotyp
characterist
vitro
determin
utr
sequenc
sbv
genom
segment
mention
predict
complet
sequenc
utr
l
segment
sbv
basi
publish
akav
sequenc
perform
race
pcr
rna
extract
sbvinfect
cell
order
establish
sequenc
ssbv
faith
repres
wild
type
field
strain
sequenc
utr
l
segment
ident
predict
sequenc
use
rescu
plasmid
ssbv
figur
find
race
pcr
extra
nucleotid
report
utr
segment
access
number
shown
repres
like
sequenc
artifact
beyond
correct
end
publish
antigenom
sequenc
found
polymorph
sbv
posit
utr
segment
clone
analyz
contain
thymin
posit
other
contain
adenin
posit
similarli
posit
clone
harbor
guanin
g
clone
contain
utr
sequenc
synthes
plasmid
use
revers
genet
contain
posit
g
posit
indic
origin
sequenc
predict
correct
figur
also
sequenc
remain
full
genom
sbv
strain
use
studi
found
ident
origin
sequenc
submit
genbank
data
shown
next
investig
whether
mice
could
use
experiment
model
sbv
infect
pathogenesi
firstli
inocul
litter
old
newborn
nihswiss
mice
n
intracerebr
pfu
sbv
ssbv
cell
cultur
media
control
studi
mice
inocul
sbv
ssbv
die
within
day
postinocul
control
mice
surviv
end
experi
figur
left
panel
data
clearli
indic
ssbv
virul
sbv
least
experiment
model
order
determin
whether
age
suscept
exist
sbv
infect
mous
model
inocul
litter
old
nihswiss
mice
describ
ssbv
studi
found
sbv
infect
lethal
infect
mice
age
group
display
similar
kinet
one
display
sbv
infect
newborn
mice
figur
right
panel
histopatholog
brain
collect
h
postinfect
reveal
bilater
symmetr
vacuol
loosen
neuropil
superfici
cerebr
cortex
mesencephalon
figur
c
particular
found
small
area
haemorrhag
within
larg
area
malacia
necrosi
brain
tissu
cerebr
cortex
figur
arrow
brain
collect
h
postinfect
figur
e
random
multifoc
vacuol
white
matter
cerebrum
small
amount
nuclear
debri
figur
minim
multifoc
perivascular
infiltr
lymphocyt
adjac
grey
matter
presenc
sbv
confirm
immunohistochemistri
use
polyclon
antibodi
n
protein
found
reactiv
mockinfect
mice
figur
g
found
patchi
area
posit
stain
brain
section
taken
mice
euthan
h
post
infect
correspond
cytoplasm
neuron
figur
extens
immunoreact
sbv
note
within
cerebrum
mesencephalon
mice
euthan
h
inocul
correspond
infect
neuron
sbv
antigen
also
detect
cell
morpholog
resembl
astrocyt
fig
jk
howev
immunofluoresc
abl
detect
sbv
cell
express
gfap
glial
fibrillari
acid
protein
specif
marker
astrocyt
data
shown
next
analys
tissu
section
brain
spinal
cord
total
natur
infect
lamb
calv
present
malform
commonli
shown
anim
congenit
infect
sbv
arthrogryposi
brachygnatia
inferior
torticolli
curvatur
spine
figur
sampl
deriv
abort
stillborn
case
occur
farm
sbvendem
area
germani
although
ascertain
time
infect
specif
sbv
strain
involv
case
histopatholog
brain
section
show
lesion
commonli
observ
sbv
infect
anim
includ
porencephali
associ
widespread
tissu
destruct
figur
cluster
myelin
laden
macrophag
fig
arrow
note
area
rarefact
glial
nodul
randomli
scatter
throughout
cerebrum
fig
arrow
mild
multifoc
perivascular
infiltr
lymphocyt
macrophagesmicroglia
immunohistochemistri
detect
sbv
predominantli
cell
bodi
process
neuron
grey
matter
similarli
observ
mice
figur
f
addit
found
express
abund
sbv
antigen
also
grey
matter
spinal
cord
figur
j
control
includ
serial
section
brain
collect
sbvinfect
anim
incub
preimmun
serum
collect
rabbit
use
product
polyclon
antibodi
sbv
n
protein
figur
h
posit
reaction
observ
sbv
posit
suspect
case
test
studi
addit
use
also
neg
control
tissu
section
collect
brain
lamb
calv
die
result
unrel
patholog
germani
collect
scotland
n
expect
none
neg
control
show
immunoreact
cell
figur
l
moreov
studi
strongli
indic
sbv
replic
neuron
brain
spinal
cord
anim
natur
infect
sbv
data
obtain
calv
lamb
suggest
newborn
nihswiss
mice
inocul
intracerebr
use
experiment
model
sbv
infect
attempt
exploit
tool
order
identifi
determin
sbv
virul
use
two
differ
approach
first
attempt
attenu
sbv
tissu
cultur
passag
viru
serial
cpttert
cell
result
viru
plaqu
purifi
twice
stock
gener
cell
reach
total
passag
tissu
cultur
viru
refer
addit
given
nss
protein
sever
bunyavirus
includ
bunv
rift
valley
fever
viru
rvfv
akav
la
cross
viru
lcv
shown
play
key
role
viral
replic
pathogenesi
attempt
rescu
revers
genet
sbv
mutant
lack
nonstructur
protein
similarli
orthobunyaviru
predict
nss
sbv
encod
segment
overlap
read
frame
within
n
gene
inher
capabl
rna
virus
mutat
revert
wild
type
phenotyp
introduc
silent
mutat
within
n
gene
abrog
second
third
initi
codon
nss
gene
moreov
introduc
prematur
stop
codon
within
nss
affect
n
read
frame
figur
result
sbv
nss
delet
mutant
term
sbvdnss
rescu
cell
describ
confirm
ident
delet
nss
mutant
sequenc
hypothes
sequenc
chang
like
occur
follow
extens
passag
plaqu
purif
tissu
cultur
consequ
amplifi
code
region
sbv
genom
segment
rtpcr
sequenc
pcr
product
directli
without
clone
identifi
total
nucleotid
chang
among
genom
segment
nonsynonym
mutat
figur
mutat
identifi
within
segment
particular
mutat
found
segment
locat
within
gc
nsm
protein
none
within
gn
found
segment
harbor
highest
number
mutat
relat
size
three
chang
found
segment
nonsynonym
mutat
n
protein
addit
mutat
also
affect
nss
protein
lead
synonym
nonsynonym
chang
next
character
vitro
growth
properti
rescu
sbvdnss
sheep
cell
figur
found
sbvdnss
compar
growth
kinet
ssbv
sbv
respect
virus
reach
similar
titer
infect
cell
thereaft
inocul
litter
old
nihswiss
mice
intracerebr
either
pfu
ssbv
sbvdnss
cell
cultur
media
control
studi
mice
inocul
ssbv
die
within
day
postinocul
except
litter
old
mice
inocul
pfu
mortal
reach
day
postinocul
figur
control
mice
healthi
end
experi
sbvdnss
show
attenu
phenotyp
clear
delay
time
death
group
inocul
sbvdnss
inocul
mice
surviv
infect
unexpectedli
virul
ssbv
experiment
model
inocul
result
lethal
day
postinfect
old
mice
respect
figur
gain
insight
natur
enhanc
pathogen
observ
mous
model
infect
inocul
litter
old
nihswiss
mice
intracerebr
ssbv
media
control
brain
sampl
collect
differ
time
point
postinfect
studi
brain
section
analyz
immunohistochemistri
detect
presenc
sbv
detect
presenc
foci
virusinfect
cell
earli
h
postinfect
sampl
deriv
mice
infect
figur
mice
sbv
antigen
wide
spread
h
postinfect
contrast
first
detect
viru
antigen
h
postinfect
brain
section
deriv
mice
infect
ssbv
result
suggest
abl
spread
faster
ssbv
brain
experiment
infect
mice
attenu
virul
display
sbvdnss
suggest
nss
protein
play
import
role
viral
pathogenesi
nss
protein
orthobunyavirus
shown
indirectli
inhibit
synthesi
ifna
b
shut
cellular
mrna
synthesi
consequ
perform
seri
assay
determin
whether
sbv
sbvdnss
induc
synthesi
ifn
infect
cell
firstli
test
human
cell
known
ifn
compet
cell
line
infect
ssbv
sbvdnss
inactiv
ifnprotect
assay
perform
cpttert
cell
respond
ifn
defect
product
data
shown
thu
good
target
cell
line
experi
virusinactiv
supernat
cell
ad
cpttert
cell
incub
h
infect
encephalomyocard
viru
emcv
viru
suscept
ifn
parallel
cell
also
incub
known
amount
univers
ifn
control
found
supernat
cell
infect
ssbv
contain
ifn
abl
protect
cpttert
cell
infect
emcv
figur
contrast
supernat
cell
infect
sbvdnss
abl
confer
protect
infect
target
cell
emcv
contain
averag
ifn
intern
unit
per
ml
iuml
secondli
investig
whether
lack
ifn
product
upon
infect
ssbv
due
inhibit
transcript
type
ifn
gene
end
investig
presenc
ifnb
mrna
rtpcr
cell
follow
infect
ssbv
sbvdnss
transfect
poli
c
posit
control
detect
ifnb
mrna
ssbvinfect
mockinfect
cell
clearli
detect
cell
infect
sbvdnss
transfect
poli
c
figur
result
suggest
sbv
nss
protein
interfer
transcript
ifnb
gene
upon
infect
furthermor
attempt
evalu
data
obtain
relev
cell
cultur
system
repeat
ifn
protect
assay
sheep
primari
endotheli
cell
cultur
ovec
ovin
trophoblast
cell
similarli
data
obtain
human
cell
found
supernat
ssbvinfect
cell
protect
cpttert
cell
infect
emcv
hand
supernat
sbvdnssinfect
ovec
found
contain
abund
amount
ifn
estim
iuml
figur
final
evalu
role
sbv
nss
protein
counteract
ifn
respons
host
vivo
inocul
litter
day
old
ifn
receptor
null
mice
ifnar
intracerebr
ssbv
n
sbvdnss
n
cultur
media
control
n
studi
control
mice
surviv
observ
period
figur
mice
inocul
sbvdnss
die
postinfect
mice
mice
infect
ssbv
die
time
point
remain
die
day
postinfect
data
strongli
suggest
anim
lack
compet
ifn
respons
equal
suscept
ssbv
sbvdnss
confirm
role
nss
protein
modul
least
indirectli
ifn
respons
vivo
sbv
new
emerg
orthobunyaviru
associ
abort
malform
sheep
cattl
bunyavirida
includ
mani
virus
emerg
reemerg
last
decad
oropv
henan
fever
viru
crimeancongo
hemorrhag
fever
rvfv
lcv
other
sbv
isol
first
time
germani
octob
howev
viru
probabl
enter
northwestern
europ
border
region
netherland
germani
belgium
subsequ
spread
rapidli
neighbor
countri
includ
luxembourg
franc
itali
spain
denmark
unit
kingdom
studi
establish
experiment
platform
compris
vitro
vivo
system
studi
sbv
biolog
pathogenesi
studi
sbv
thu
far
concentr
understand
anim
speci
suscept
viru
spread
infect
impact
anim
health
farm
industri
studi
undertook
sever
step
toward
understand
molecular
biolog
sbv
cellular
tropism
pathogenesi
hostviru
interact
use
synthet
biolog
approach
develop
two
revers
genet
protocol
sbv
power
tool
character
emerg
pathogen
manipul
genom
use
sbv
sequenc
deposit
public
databas
synthes
three
sbv
antigenom
segment
vitro
rescu
replic
compet
sbv
transfect
cell
previous
describ
bunyavirus
also
develop
altern
rescu
system
use
plasmid
transient
transfect
cell
rna
polymeras
provid
tran
use
race
rtpcr
perform
viral
rna
extract
earli
passag
sbv
stock
confirm
sequenc
ident
viral
utr
synthet
plasmid
inde
correspond
sbv
allow
us
provid
first
time
fulllength
sequenc
circul
sbv
sinc
previou
report
provid
partial
sequenc
viral
utr
synthet
sbv
ssbv
obtain
abl
replic
vitro
effici
wild
type
sbv
addit
wild
type
ssbv
lethal
suckl
mice
inject
intracerebr
experiment
mous
system
prove
use
order
defin
sbv
tropism
histolog
lesion
within
brain
mice
inocul
sbv
show
progress
peracut
hemorrhag
h
postinfect
malacia
h
extend
widespread
vacuol
white
matter
h
postinocul
strong
immunoreact
sbv
within
cerebr
neuron
mice
euthan
earli
h
postinocul
confirm
histolog
chang
within
brain
relat
sbv
infect
importantli
also
found
sbv
replic
neuron
utero
infect
calv
lamb
fetal
sheep
sbv
infect
result
cavit
white
matter
cerebrum
cerebellar
hypoplasia
mild
lymphohistiocyt
perivascular
enceph
small
glial
nodul
scatter
throughout
brain
thu
cavitari
lesion
observ
natur
sbv
infect
lambscalv
appear
natur
progress
vacuolar
chang
within
white
matter
observ
suckl
mice
acut
infect
sbv
similar
patholog
chang
natur
infect
fetal
sheep
mice
inocul
sbv
intracerebr
suggest
mous
use
model
studi
least
aspect
sbv
virul
studi
made
substanti
progress
gener
sbv
antiserum
allow
us
defin
neuron
brain
seem
major
target
viral
replic
develop
fetu
limit
time
frame
sheep
fetus
seem
suscept
sbv
infect
day
gestat
coincid
develop
blood
brain
barrier
bbb
sheep
bbb
start
develop
day
gestat
reach
full
develop
day
thu
viru
could
easi
access
brain
fetu
short
period
time
day
gestat
placentom
function
unit
exchang
mother
fetu
rumin
placenta
develop
day
bbb
start
develop
would
explain
diseas
adult
anim
intact
bbb
mild
appar
develop
lesion
cn
newborn
mice
fulli
matur
bbb
howev
develop
cerebr
vessel
fragil
allow
leakag
infecti
agent
sbv
could
potenti
reach
mous
brain
tissu
subcutan
inocul
prove
character
schmallenberg
viru
plo
pathogen
wwwplospathogensorg
opportun
develop
challeng
model
infect
would
better
mimic
natur
exposur
report
subcutan
inocul
ifnar
mice
sbv
result
weight
loss
mortal
therefor
differ
aspect
sbv
infect
could
explor
also
model
malform
deform
observ
sbvinfect
lamb
calv
accompani
muscl
hypoplasia
demyelin
found
sbv
infect
neuron
grey
matter
spinal
cord
would
suggest
muscular
hypoplasia
muscular
defect
observ
sbv
infect
lamb
calv
mostli
secondari
damag
central
nervou
system
cn
use
revers
genet
engin
sbv
nss
delet
mutant
protein
found
orthobunyavirus
virul
factor
act
inhibit
cellular
transcript
therefor
indirectli
antagon
host
ifn
respons
sbvdnss
replic
level
compar
wild
type
sbv
establish
cell
line
indic
nss
protein
essenti
viral
replic
vitro
howev
sbvdnss
strongli
attenu
newborn
mice
unlik
attenu
observ
sbvdnss
due
chang
cell
tropism
contrari
attribut
attenu
phenotyp
inabl
counteract
innat
immun
respons
host
support
fact
abl
detect
induct
ifn
ifncompet
human
cell
line
sheep
primari
cell
infect
sbvdnss
infect
wild
type
sbv
product
ifn
sbvdnssinfect
cell
associ
presenc
ifnb
transcript
detect
cell
infect
wild
type
sbv
indic
inhibit
ifn
product
occur
level
transcript
importantli
found
differ
virul
ssbv
sbvdnss
ifnar
mice
reinforc
notion
sbv
nss
protein
abl
modul
least
indirectli
host
innat
immun
respons
thu
nss
protein
sbv
act
virul
factor
similar
role
identifi
nss
protein
rvfv
lcv
underli
import
overcom
host
innat
immun
respons
effici
viral
replic
attempt
identifi
determin
sbv
virul
serial
passag
sbv
cpttert
cell
normal
serial
passag
pathogen
virus
cell
cultur
result
decreas
virul
especi
cell
use
defect
product
factor
mediat
innat
immun
respons
howev
use
approach
unexpectedli
obtain
sbv
mutant
increas
pathogen
suckl
mice
appear
spread
rapidli
sbv
brain
infect
anim
accumul
varieti
mutat
viral
segment
one
found
segment
potenti
interest
one
given
alreadi
shown
nss
virul
factor
ii
mutat
found
segment
present
gc
protein
expos
outer
surfac
virion
thu
princip
target
neutral
antibodi
mutat
gener
gc
immunolog
unconstrain
environ
could
associ
exampl
increas
cell
receptor
affin
conclus
synthet
biolog
approach
demonstr
least
bunyavirida
possibl
rapidli
investig
character
emerg
viru
whilst
knowledg
complet
sequenc
viru
use
synthet
plasmid
develop
revers
genet
protocol
rescu
replic
compet
sbv
importantli
develop
mous
model
infect
allow
us
identifi
viral
gene
critic
virul
viral
tropism
neuron
cn
shown
similar
experiment
infect
mice
natur
infect
calv
lamb
altogeth
molecular
virolog
tool
gener
find
work
open
new
avenu
studi
biolog
pathogenesi
novel
rapidli
spread
emerg
viru
experiment
procedur
carri
studi
approv
ethic
committe
istituto
g
caporal
protocol
number
approv
italian
ministri
health
ministero
della
salut
accord
council
direct
eec
european
union
italian
dig
bsr
mdck
cell
line
grown
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
provid
karl
conzelmann
cell
stabli
express
polymeras
grown
glasgow
modifi
eagl
medium
supplement
fb
tryptos
phosphat
broth
final
concentr
mgml
sheep
choroid
plexu
cell
cpttert
grown
iscov
modifi
dulbecco
medium
supplement
fb
provid
david
griffith
bovin
fetal
aorta
endotheli
cell
bfae
health
protect
agenc
collect
number
cultur
ham
medium
supplement
fb
ovin
trophoblast
cell
provid
thoma
spencer
cultur
media
supplement
fb
mm
pyruv
nm
human
recombin
insulin
mm
nonessenti
amino
acid
cell
line
cultur
co
humidifi
atmospher
supplement
uml
penicillin
mgml
streptomycin
ovin
aortic
endotheli
ovec
cell
isol
collagenas
treatment
use
method
adapt
gillespi
et
al
aorta
harvest
recent
euthan
anim
wash
twice
steril
pb
aorta
incub
room
temperatur
h
dmem
supplement
fb
mgml
penicillinstreptomycin
ngml
amphotericin
b
incub
aorta
place
collagenas
petri
dish
mgml
dmem
h
incub
endotheli
cell
remov
scrape
seed
plate
cell
maintain
co
larg
vessel
endotheli
cell
basal
medium
tc
cellwork
supplement
fb
human
larg
vessel
endotheli
cell
growth
supplement
tc
cellwork
mgml
penicillinstreptomycin
ngml
amphotericin
b
cell
confirm
endotheli
cell
assess
morpholog
use
light
microscopi
immunofluoresc
use
antibodi
endotheli
smooth
muscl
cell
marker
cell
use
studi
passag
antisera
use
studi
includ
rabbit
polyclon
antiserum
sbv
n
protein
express
bacteria
glutathionestransferas
gst
tag
recombin
protein
proteintech
antibodi
marker
endotheli
cell
actin
smooth
muscl
marker
purchas
sourc
bioscienc
abcam
respect
wild
type
sbv
origin
isol
friedrichloefflerinstitut
germani
viru
initi
isol
blood
infect
cow
passag
kc
cell
time
cell
viru
plaqu
purifi
stock
produc
cell
viru
titer
determin
standard
plaqu
assay
cpttert
cell
express
plaqu
form
unit
per
millilit
pfuml
encephalomyocard
viru
provid
rick
randal
plasmid
encod
fulllength
antigenom
l
sbv
segment
use
sbv
revers
genet
protocol
describ
studi
see
plasmid
sbv
antigenom
place
downstream
bacteriophag
promot
upstream
hepat
ribozym
termin
similarli
describ
previous
bunyavirus
sequenc
synthes
commerci
deriv
incomplet
sbv
sequenc
avail
genbank
januari
miss
end
sequenc
genom
segment
avail
genbank
time
predict
align
akav
sequenc
obtain
insert
point
mutat
describ
two
mutat
cell
cell
plate
well
plate
one
day
transfect
without
final
volum
ml
tissu
cultur
media
without
antibiot
rescu
cell
mg
antigenomeencod
plasmid
transfect
use
fugen
hd
ratio
mg
plasmid
ml
fugen
rescu
cell
plasmid
express
polymeras
control
cmv
promot
transfect
alongsid
plasmid
contain
sbv
antigenom
deriv
delet
mutant
antigenom
protocol
cell
transfect
two
genom
segment
use
neg
control
supernat
collect
day
post
transfect
clarifi
low
speed
centrifug
presenc
viru
term
ssbv
synthet
sbv
studi
assess
standard
plaqu
assay
cpttert
cell
alreadi
describ
viru
stock
gener
plaqu
purifi
viru
cpttert
cell
vitro
growth
kinet
sbv
determin
infect
varieti
cell
line
multipl
infect
moi
presenc
infecti
viru
assess
clarifi
supernat
collect
differ
time
point
post
infect
end
point
dilut
analysi
perform
cpttert
cell
experi
perform
triplic
repeat
least
twice
end
genom
segment
sbv
sequenc
use
race
kit
accord
manufactur
instruct
roch
race
carri
genom
strand
obtain
sequenc
end
viru
segment
briefli
mg
total
rna
extract
sbv
infect
cell
revers
transcrib
use
gene
specif
cdna
synthesi
primer
synthesis
cdna
column
purifi
polya
tail
end
amplifi
use
oligodt
anchor
primer
second
nest
gene
specif
primer
obtain
end
viru
segment
race
perform
genom
strand
briefli
mg
total
rna
extract
sbv
infect
cell
polya
tail
end
rna
use
poli
polymeras
neb
accord
manufac
turer
protocol
polya
tail
rna
revers
transcrib
use
oligodt
anchor
primer
cdna
amplifi
use
anchor
primer
nest
gene
specif
primer
primer
sequenc
avail
upon
request
interferon
detect
cell
plate
densiti
cellsml
well
plate
cell
infect
indic
virus
moi
transfect
poli
c
ng
use
lipofectamin
accord
manufactur
protocol
cell
incub
h
lyse
trizol
reagent
invitrogen
rna
extract
accord
manufactur
protocol
mg
total
rna
revers
transcrib
use
superscript
iii
invitrogen
accord
manufactur
instruct
cdna
use
templat
amplif
sbv
segment
rna
use
gotaq
polymeras
promega
follow
manufactur
protocol
sequenc
primer
use
sbv
detect
avail
request
primer
amplif
ifnb
rna
previous
publish
measur
ifn
level
base
method
describ
previous
ovec
cell
first
seed
plate
incub
day
cell
infect
appropri
viru
moi
respect
medium
collect
h
later
medium
uvtreat
minut
use
spectrolink
uv
crosslink
spectron
corpor
order
remov
infecti
viru
cpttert
cell
seed
plate
h
later
serial
dilut
duplic
uvtreat
media
ad
cell
incub
h
parallel
cell
also
incub
dilut
known
amount
univers
ifn
cell
infect
encephalomyocard
viru
emcv
incub
addit
h
level
ifn
calcul
monitor
well
protect
cell
death
induc
emcv
compar
univers
ifn
control
sdspage
western
blot
perform
total
cell
lysat
prepar
h
postinfect
previous
describ
sbv
detect
use
rabbit
polyclon
antibodi
sbv
nucleocapsid
protein
anim
experi
carri
istituto
g
caporal
teramo
itali
follow
local
nation
approv
protocol
anim
experiment
studi
litter
old
nihswiss
mice
inocul
intracerebr
pfu
sbv
ssbv
mock
inocul
use
cell
cultur
medium
anim
monitor
daili
sign
diseas
period
day
studi
litter
old
nihswiss
mice
inocul
intracerebr
pfu
ssbv
monitor
sign
diseas
studi
litter
old
mice
inocul
intracerebr
pfu
ssbv
sbvdnss
cell
cultur
media
monitor
sign
diseas
period
day
studi
litter
old
nihswiss
mice
inocul
intracerebr
pfu
ssbv
cell
cultur
media
anim
per
group
euthan
h
postinfect
studi
litter
day
old
mice
defici
type
ifn
receptor
ifn
alpha
roo
ifn
inocul
intracerebr
pfu
ssbv
sbvdnss
cell
cultur
media
control
monitor
sign
diseas
brain
infect
control
mice
collect
fix
neutral
buffer
formalin
paraffin
embed
follow
standard
histolog
procedur
addit
brain
tissu
also
collect
lamb
calv
born
north
rhinewestphalia
sbvendem
area
germani
postmortem
anim
present
varieti
malform
includ
arthrogryposi
brachygnatia
torticolli
cerebellar
hypoplasia
hydrocephalu
muscular
hypoplasia
neg
control
includ
brain
section
deriv
sheep
calv
die
result
diseas
unrel
sbvinfect
germani
also
use
neg
control
brain
tissu
scotland
area
far
free
sbv
infect
tissu
section
mm
mice
lamb
calv
stain
hematoxylin
eosin
histopatholog
examin
section
also
examin
presenc
sbv
n
protein
use
specif
antiserum
envis
dako
detect
system
describ
sequenc
synthet
sbv
genom
segment
deposit
genbank
access
number
